Chasing the vaccine
Vaxgen, a California-based pharmaceutical company, is valiantly seeking to enlarge a faint silver lining as it presents findings of four years of research on its Aids vaccine. Aidsvax, the first Aids
Vaxgen, a California-based pharmaceutical company, is valiantly seeking to enlarge a faint silver lining as it presents findings of four years of research on its Aids vaccine. Aidsvax, the first Aids